Abstract

Universal stool banks rely on, but face difficulties recruiting, community volunteers to donate stool for faecal microbiota transplantation (FMT) to effectively treat recurrent Clostridioides difficile. This study sought to identify determinants of community members' willingness to donate stool to guide donor recruitment. 397 Australian residents (52% male, 47% 21-30 years, 63% university educated) completed a survey to gauge willingness to donate stool, bowel habits, information needs, attitudes, barriers, and motives for donation. Most reported regular bowel movements (BMs; 90%), morning BMs (63%), BMs ≤5 minutes duration (67%), and some discomfort doing BMs in public restrooms (69%). Less than half were willing to donate stool in-centre (45% willing) or at home (48%). Important information needs identified by >80% were convenience and travel requirements associated with donation. Main barriers were logistics, capabilities to donate, disgust (e.g., donation process), and discomfort (e.g., privacy). The main motivator was altruism, with compensation secondary. Linear regression models identified less discomfort doing BMs in public restrooms (β = -0.15), understanding benefits to patients (β = 0.15), placing less importance on understanding the donation process (β = -0.13), and positive attitudes (β = 0.56) as determinants of willingness to donate in-centre. Understanding benefits to self (β = 0.11) and patients (β = 0.24), placing less importance on understanding the donation purpose (β = -0.19), and positive attitudes (β = 0.50) determined willingness to donate at home. Stool banks should consider donor's bowel habits, comfort donating in-centre, and information needs early in recruitment; and implement flexible logistics for potential donors who face time constraints and limited access to stool banks.

Highlights

  • Faecal microbiota transplantation (FMT) is a highly effective treatment for the 20%-30% of patients who develop recurrent Clostridioides difficile infection (CDI) after first-line treatment with antibiotics [1], and shows promise for other inflammatory bowel diseases and gastrointestinal conditions [2,3,4]

  • This study provides the first insight into the Australian community’s willingness to donate stool

  • Human Research Ethics Approval was obtained from The University of Queensland (Approval number 2020000029) and Australian Red Cross Lifeblood (Approval number 2020#03) committees

Read more

Summary

Introduction

Faecal microbiota transplantation (FMT) is a highly effective treatment for the 20%-30% of patients who develop recurrent Clostridioides difficile infection (CDI) after first-line treatment with antibiotics [1], and shows promise for other inflammatory bowel diseases and gastrointestinal conditions [2,3,4]. Successful treatment of recurrent CDI and prevention of recurrence occurs for 70–90% of FMT recipients [1], as well as health care savings following FMT

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call